These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3520204)

  • 41. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
    Wirth S; Sokal E; Schaefer E; Pohlenz J; Keller KM
    Monatsschr Kinderheilkd; 1992 Oct; 140(10):775-9. PubMed ID: 1435800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes of anti-HB core antibody in children with positive HB surface antigen.
    Kagimoto S; Fujitsuka S; Onoue M; Fujisawa T; Yoshioka S; Hino K
    Acta Paediatr Jpn; 1991 Jun; 33(3):317-22. PubMed ID: 1785326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus.
    Hadziyannis SJ; Lieberman HM; Karvountzis GG; Shafritz DA
    Hepatology; 1983; 3(5):656-62. PubMed ID: 6618432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of anti-HBe-positive and HBe-antigen-positive chronic hepatitis B in France. French Multicentre Group.
    Zarski JP; Marcellin P; Cohard M; Lutz JM; Bouche C; Rais A
    J Hepatol; 1994 May; 20(5):636-40. PubMed ID: 8071540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-DNA, anti-HBc correlations with RIA-detected HBeAg and anti-HBe in chronic HBsAg carriers.
    Villarejos VM; Andersen-Visoná K; Serra J; Frösner GG; Deinhardt F
    J Med Virol; 1980; 5(4):265-71. PubMed ID: 7229619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intrahepatic lymphocyte subpopulation defined by monoclonal antibodies in anti-HBe positive type B chronic active hepatitis.
    Yamada G; Hyodo I; Nishihara T; Nagashima H
    Gastroenterol Jpn; 1985 Oct; 20(5):441-6. PubMed ID: 4076728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigations on HBe antigen. Note II. Dynamics of HBsAg in acute viral hepatitis, according to HBeAg persistence or seroconversion.
    Babeş VT; Cepănaru S; Cepănaru R; Tănase M
    Virologie; 1981; 32(3):187-91. PubMed ID: 7303492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of acute viral hepatitis with (+)-cyanidanol-3.
    Blum AL; Berthet P; Doelle W; Goebell H; Kortüm K; Pelloni S; Peter P; Poulsen H; Strohmeyer G; Tygstrup N
    Lancet; 1977 Dec; 2(8049):1153-5. PubMed ID: 73062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multicenter randomized controlled clinical trial of Shosaiko-to in chronic active hepatitis.
    Hirayama C; Okumura M; Tanikawa K; Yano M; Mizuta M; Ogawa N
    Gastroenterol Jpn; 1989 Dec; 24(6):715-9. PubMed ID: 2691317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Study of therapy in chronic liver diseases. Double-blind study with cianidanol].
    Machalke K; Müller B
    Fortschr Med; 1982 Apr; 100(14):665-7. PubMed ID: 6123478
    [No Abstract]   [Full Text] [Related]  

  • 51. Determinants for hepatitis B e antigen clearance in chronic type B hepatitis.
    Liaw YF; Chu CM; Huang MJ; Sheen IS; Yang CY; Lin DY
    Liver; 1984 Oct; 4(5):301-6. PubMed ID: 6503634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study.
    Wong VC; Ip HM; Reesink HW; Lelie PN; Reerink-Brongers EE; Yeung CY; Ma HK
    Lancet; 1984 Apr; 1(8383):921-6. PubMed ID: 6143868
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The immunoenhancing effect of cianidanol (C) on macrophages and on the T-cell system.
    Rauch G
    Methods Find Exp Clin Pharmacol; 1986 Mar; 8(3):147-50. PubMed ID: 3487015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of adenine arabinoside and alpha-interferon in patients with HBeAg-positive chronic active hepatitis.
    Lee SU; Choi KH; Ha BJ; Suh SY; Han BH; Ku JY; Park BC
    Korean J Intern Med; 1990 Jan; 5(1):1-4. PubMed ID: 2271507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of cianidanol on natural killer cell activity in patients with chronic B virus hepatitis.
    Pár A; Szekeres-Bartho J; Pácsa S; Jávor T
    Int J Clin Pharmacol Res; 1987; 7(4):301-6. PubMed ID: 3596873
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and virological characteristics of chronic hepatitis B with concurrent hepatitis B E antigen and antibody detection.
    Wang J; Zhou B; Lai Q; Wang Y; Shen G; Wang Z; Chen J; Hou J
    J Viral Hepat; 2011 Sep; 18(9):646-52. PubMed ID: 20636332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The window period between hepatitis B e antigen and antibody in chronic type hepatitis.
    Liaw YF; Huang MJ; Chu CM; Sheen IS; Lin DY
    Hepatology; 1984; 4(4):619-21. PubMed ID: 6745849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. (+)-Cyanidanol-3 in the treatment of acute viral hepatitis: a randomized controlled trial.
    Schomerus H; Wiedmann KH; Dölle W; Peerenboom H; Strohmeyer G; Balzer K; Goebell H; Dürr HK; Bode C; Blum AL
    Hepatology; 1984; 4(2):331-5. PubMed ID: 6368355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests.
    Hasan KN; Rumi MA; Hasanat MA; Azam MG; Ahmed S; Salam MA; Islam LN; Hassan MS
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IgG subclasses in circulating immune complexes with hepatitis B e antigen in chronic hepatitis B.
    Sällberg M; Norder H; Lindh G; Magnius LO
    Clin Exp Immunol; 1991 Apr; 84(1):116-21. PubMed ID: 2015701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.